[go: up one dir, main page]

ATE218558T1 - 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen - Google Patents

4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen

Info

Publication number
ATE218558T1
ATE218558T1 AT97953824T AT97953824T ATE218558T1 AT E218558 T1 ATE218558 T1 AT E218558T1 AT 97953824 T AT97953824 T AT 97953824T AT 97953824 T AT97953824 T AT 97953824T AT E218558 T1 ATE218558 T1 AT E218558T1
Authority
AT
Austria
Prior art keywords
benzosic
piperazinyl
production
acid derivatives
therapeutic uses
Prior art date
Application number
AT97953824T
Other languages
English (en)
Inventor
Gerard Moinet
Gerard Botton
Liliane Doare
Micheline Kergoat
Didier Messangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE218558T1 publication Critical patent/ATE218558T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
AT97953824T 1996-12-18 1997-12-15 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen ATE218558T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
PCT/EP1997/007046 WO1998027078A1 (en) 1996-12-18 1997-12-15 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications

Publications (1)

Publication Number Publication Date
ATE218558T1 true ATE218558T1 (de) 2002-06-15

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97953824T ATE218558T1 (de) 1996-12-18 1997-12-15 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen

Country Status (26)

Country Link
US (1) US6281215B1 (de)
EP (1) EP0937054B1 (de)
JP (1) JP2001506645A (de)
KR (1) KR20000069544A (de)
CN (1) CN1073102C (de)
AR (1) AR013889A1 (de)
AT (1) ATE218558T1 (de)
AU (1) AU726640B2 (de)
BR (1) BR9713587A (de)
CA (1) CA2275346A1 (de)
CZ (1) CZ218999A3 (de)
DE (1) DE69713128T2 (de)
DK (1) DK0937054T3 (de)
ES (1) ES2178039T3 (de)
FR (1) FR2757158B1 (de)
HU (1) HUP0000586A3 (de)
ID (1) ID23671A (de)
NO (1) NO312896B1 (de)
PL (1) PL334187A1 (de)
PT (1) PT937054E (de)
RU (1) RU2178786C2 (de)
SK (1) SK282841B6 (de)
TR (1) TR199901367T2 (de)
UA (1) UA56206C2 (de)
WO (1) WO1998027078A1 (de)
ZA (1) ZA9711329B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
KR100502229B1 (ko) * 1995-02-28 2005-11-08 다이이찌 산토리 파마 가부시키가이샤 아릴피페리딘및아릴피페라진유도체,및이를함유하는약제

Also Published As

Publication number Publication date
ZA9711329B (en) 1998-06-24
UA56206C2 (uk) 2003-05-15
FR2757158A1 (fr) 1998-06-19
NO312896B1 (no) 2002-07-15
ID23671A (id) 2000-05-11
EP0937054B1 (de) 2002-06-05
SK282841B6 (sk) 2002-12-03
AU726640B2 (en) 2000-11-16
SK78599A3 (en) 2000-03-13
BR9713587A (pt) 2000-04-04
PL334187A1 (en) 2000-02-14
CN1245494A (zh) 2000-02-23
ES2178039T3 (es) 2002-12-16
US6281215B1 (en) 2001-08-28
FR2757158B1 (fr) 1999-04-02
TR199901367T2 (xx) 1999-10-21
JP2001506645A (ja) 2001-05-22
AU5758298A (en) 1998-07-15
AR013889A1 (es) 2001-01-31
DK0937054T3 (da) 2002-09-16
CN1073102C (zh) 2001-10-17
HUP0000586A2 (hu) 2001-04-28
WO1998027078A1 (en) 1998-06-25
HUP0000586A3 (en) 2002-10-28
NO992968D0 (no) 1999-06-17
EP0937054A1 (de) 1999-08-25
KR20000069544A (ko) 2000-11-25
RU2178786C2 (ru) 2002-01-27
DE69713128T2 (de) 2003-03-20
PT937054E (pt) 2002-11-29
DE69713128D1 (de) 2002-07-11
NO992968L (no) 1999-08-17
CZ218999A3 (cs) 1999-09-15
CA2275346A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
DE50011035D1 (de) Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE60033028D1 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE69724142D1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
DE50014587D1 (de) 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
ATE169018T1 (de) Tetracyclische derivate, verfahren zu ihrer herstellung und ihre verwendung
DE59307218D1 (de) Modifizierte polyasparaginsäuren, verfahren zu ihrer herstellung und ihre verwendung
DE50102147D1 (de) Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59707976D1 (de) Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE60103395D1 (de) 1,4-diazabicyclo[3.2.2]nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ATE172196T1 (de) 2- (2-alkoxy-6-trifluormethylpyrimidin-4-yl)- oxymethylen>-phenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung
ATE210638T1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE50011179D1 (de) Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE204268T1 (de) Diarylmethylidenefuran-derivate, verfahren zu deren herstellung und ihre verwendungen in therapie
ATE218558T1 (de) 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen
DE59608892D1 (de) Iminooxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung
DE59902408D1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
ATE263755T1 (de) Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE313556T1 (de) Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung
ATE200080T1 (de) Benzoxazindionderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69711911D1 (de) Aryloxypropanolaminderivate, verfahren zu deren herstellung und deren verwendungen
ATE224890T1 (de) Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin- 0-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69732570D1 (de) Sulfonsäureester-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE59810800D1 (de) Benzylaminderivate und phenylethylaminderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE205481T1 (de) Iminooxybenzylcrotonsäureester, verfahren zu ihrer herstellung und ihre verwendung
DE69718308D1 (de) 4-fluorsalicylsäurederivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee